There are several studies indicating the role of CCN2/CTGF protein as a biomarker for cardiovascular diseases and report that plasma levels of CCN2/CTGF protein correlate with the plasma levels of the known hypertrophy marker BNP in patients with heart failure. This evidence concerns the gene CCN2 and cardiovascular disorder.